Silk Road Medical to Report Third Quarter 2023 Financial Results on November 8, 2023
October 26 2023 - 4:30PM
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on
reducing the risk of stroke and its devastating impact, today
announced it will report financial results for the third quarter
2023 after market close on Wednesday, November 8th, 2023. Company
management will host a corresponding audio webcast beginning at
1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Those interested in listening to the conference
call should register online using this link. Participants are
encouraged to register more than 15 minutes before the start of the
call. A live and replay version of the webcast will be available at
https://investors.silkroadmed.com.
About Silk Road MedicalSilk Road
Medical, Inc. (NASDAQ: SILK), is a medical device company located
in Sunnyvale, California, and Plymouth, Minnesota, that is focused
on reducing the risk of stroke and its devastating impact. The
company has pioneered a new approach for the treatment of carotid
artery disease called TransCarotid Artery Revascularization (TCAR).
TCAR is a clinically proven procedure combining surgical principles
of neuroprotection with minimally invasive endovascular techniques
to treat blockages in the carotid artery at risk of causing a
stroke. For more information on how Silk Road Medical is delivering
brighter patient outcomes through brighter clinical thinking, visit
www.silkroadmed.com and connect on Twitter, LinkedIn and
Facebook.
Investor Contact:Lynn Lewis or
Marissa BychGilmartin Groupinvestors@silkroadmed.com
Silk Road Medical (NASDAQ:SILK)
Historical Stock Chart
From Sep 2024 to Oct 2024
Silk Road Medical (NASDAQ:SILK)
Historical Stock Chart
From Oct 2023 to Oct 2024